Rodelis backtracks on price hike for TB med; India's Glenmark looks to U.S. for growth;

@FiercePharma: China's WuXi NextCODE builds on Fudan University partnership with Children's Hospital pact. FiercePharmaAsia story | Follow @FiercePharma

@EricPFierce: Novo to build a $78M insulin pen plant in Iran. FiercePharmaManufacturing news | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: New ulcerative colitis data could help Pfizer's Xeljanz pick up the pace. Article | Follow @CarlyHFierce

> Under pressure, Rodelis Therapeutics--which had jacked up prices on TB med cycloserine--agreed to return the drug to its previous owner, a non-profit organization. Report

>  India's Glenmark Pharmaceuticals is counting on strong growth in the U.S. to offset weakness in emerging markets this year, its CEO said. Report

> AmerisourceBergen ($ABC) has authorized a special $2.4 billion share repurchase program to mitigate a possible dilution from the exercise of warrants issued to Walgreens Boots Alliance ($WBA) in 2013. Report

> Police in Gloucester, MA, are imploring people to contact the CEOs of Abbott Laboratories ($ABT), Pfizer ($PFE), Johnson & Johnson ($JNJ), Eli Lilly ($LLY) and Merck ($MRK) to ask what they're doing to curb opioid abuse. More

> South African police have shut down three counterfeit drug plants in a swoop. Report

> Bayer's CropScience unit has reached a $5.6 million settlement over an explosion at a West Virginia pesticide facility that killed two people in 2008. More

> In a study, people who suffered a heart attack lived longer when their dose of beta-blocker was a quarter of the amount commonly prescribed, researchers said Monday. Report

Medical Device News

@FierceMedDev: Sequenom appoints new CEO amid diversification. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: CMS proposal to restrict coverage of artificial limbs facing pushback from amputees. Story | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: Clorox reveals smartphone-powered UV cleaning device for drug-resistant bacteria. Article | Follow @EmilyWFierce

> Biogen VP Karaboutis rallies company for med tech R&D push. More

> NIH gives med tech company $1.9M to improve deep brain stimulation for Parkinson's. Story

Biotech News

@FierceBiotech: Why would Martin Shkreli hike an old drug price by 5000%? Only a 'moron' would ask. More | Follow @FierceBiotech

@JohnCFierce: The British papers seem particularly outraged by Shkreli. Feeling a bit sorry/outraged for the Yanks? Understandable. | Follow @JohnCFierce

@DamianFierce: "Industry analysts often cite the day Taiwanese animators got involved as the peak of the biotech bubble." Watch | Follow @DamianFierce

> Henri Termeer backs biotech upstart Artax's autoimmune research. Story

> AstraZeneca embraces crowdsourcing in a mix-and-match cancer R&D contest. Article

> Deerfield leads a $75M round for Akari. More

Drug Delivery News

> Drug-carrying nanoparticles disguised as platelets could help heal blood vessels. Report

> BDSI touts fed's plan to remove barriers on medication-assisted treatment of drug addiction. More

> West Pharma adds medication adherence tracking capability to its drug delivery system. Item

> Silicone vaginal ring could deliver HIV, herpes drugs at low cost. Story

> Impel NeuroPharma bags $4M to develop its device to deliver drugs across blood-brain barrier. Article

Pharma Manufacturing News

> Huge Russian plasma products plant moving forward. Article

> Novo to build $78M plant in Iran. News

> China's ShangPharma to build biologics plant in Qidong. Story

> GSK sets up network to help its suppliers cut emissions. Item

> McKesson nails down another international supply chain deal. Report

Pharma Asia News

> Serum Institute pushes for dengue cure fast track, Times of India says. Article

> WuXi NextCODE bolsters Fudan University alliance with Children's Hospital pact. News

> Novartis CEO says company to make heart failure drug Entresto at Singapore plant. Item

> Shanghai-based ZAI Lab in-licenses autoimmune candidate from UCB. Story

> China's BGI and Huawei partner on Big Data genomic system storage. More

And Finally... The ancestors of the Inuit evolved unique genetic adaptations for metabolizing omega-3s and other fatty acids, a new study says. More (sub. req.)

Suggested Articles

AbbVie has seen blossoming market share for immunology launches Rinvoq and Skyrizi—and it's eyeing Allergan's neurology biz for a boost, too.

While Novo's Rybelsus launch has slowed due to the pandemic, another version of the med, Ozempic posted strong sales.

AZ sold Atacand and Atacand Plus rights in about 70 countries to Cheplapharm.